Our Medical Oncologists assist patients with chemotherapy, immunotherapy, phlebotomy, pre-arranged injections, and bone marrow aspiration and biopsy.
Patients may undergo treatments such as Brachytherapy (HDR), Intensity Modulation Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), Stereotactic Radiosurgery (SRS), and 3D conformal radiation therapy.
Our team works with the surgeons at UPMC Western Maryland with a vast experience in oncological surgeries, who complete minimally invasive surgeries and can help relieve other symptoms caused by cancer.
We offer a variety of research studies that give you the opportunity to improve your health and future cancer treatments.
Patients may visit our Diagnostic Imaging as often as needed for a current and accurate view of their cancer.
While going through cancer treatment, patients have the option to seek additional support through a nurse navigator, pastoral care providers, social workers, dieticians, and more.
Common Cancers Treated at the SFCC
All Adult Cancer
At Schwab Family Cancer Center, we diagnose and treat all forms of adult cancer, from more common conditions such as lung, skin, and breast cancer, to rarer malignancies, such as mesothelioma, throat cancer and brain cancer.
If you or your loved one has a form of adult cancer, we’re here to give you the treatment needed and answers any questions you may have.
Breast cancer develops when cells in the breast tissue become malignant. Women make up approximately 99 percent of breast cancer patients. According to the National Breast Cancer Foundation, one woman in eight will receive a breast cancer diagnosis at some point in her lifetime.
While the exact cause of breast cancer remains unknown, medical researchers do know that it’s caused by damage to the DNA of breast tissue cells. Women with a family history of breast cancer are more likely to develop the disease themselves and should discuss their risks with their doctor.
Colon cancer frequently begins as a polyp, which is a growth in the colon or rectum. Every year, approximately 95,000 people receive a diagnosis of colon cancer and 40,000 learn they have rectal cancer.
The risk of developing colorectal cancer, the term for both colon and rectal cancer, is approximately 4.5 percent over the course of a person’s life. Survival rates have increased dramatically over the last several years due to routine colonoscopies and earlier removal of polyps.
With lung cancer, cells lining the respiratory system airways become malignant. Although smoking is a frequent cause, non-smokers can also develop lung cancer. Other risk factors include exposure to second-hand smoke, radon gas, asbestos fibers, and normal aging. Uncontrolled cell growth can occur in one or both lungs.
This prevents the development of healthy lung tissue, which eventually causes difficulty breathing and interference with the lung delivering blood to the rest of the body. UPMC Western Maryland has lung cancer screening program to help diagnose lung cancers earlier than before.
This type of cancer develops in the white blood cells called lymphocytes. Your lymph system contains numerous cells and organs, including the lymph nodes, liver, spleen, and thymus glands. Your lymph system produces T-Cells and B-Cells that make up its immune system. These cells travel to your circulatory and lymphatic system fighting viruses and infections.
You may receive a diagnosis of Hodgkin’s lymphoma, which involves a mutation of specific cells, or non-Hodgkin’s lymphoma, which involves mutation of the T-Cells and B-Cells. Approximately 140,000 people receive a diagnosis of lymphoma, leukemia, or myeloma annually, all of which are blood cancers.
The prostate is a small part of a male’s reproductive system. This type of cancer begins in the prostate gland when cells begin growing out of control. The prostate, which sits in front of the rectum and below the bladder, is walnut-sized and helps to make semen. Prostate cancer is the second most common form of cancer in the United States with approximately 161,000 new cases each year. This disease is highly treatable, especially in the early stages. The SFCC oncology team will explain the disease, treatment options, and realistic survival rates for every patient.